SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (1818)3/12/2003 6:06:46 PM
From: Biomaven  Read Replies (1) of 2243
 
Rick,

I'd say KOSN is a big stretch as a 50-bagger. More reasonable as a potential 10- or 20-bagger.

50-baggers are very rare beasts indeed. Realistically you have to look in the sub-$100m market cap area, and in today's environment you need a decent amount of cash as well. Not too many companies with decent projects fall into that category.

Thus a company like TLRK could certainly strike it big, but with a MC of over $200m it would need to reach over $10 billion MC to make it a 50-bagger. Kind of tough (but not totally impossible) to see that happening.

ALT was my one suggestion as a 50-bagger:

Message 18469795

Of course it would only need to be a 25-bagger from here for that forecast to come true, as it's about doubled since then. (I own only a very small amount). It's still going to live or die based on its trial results expected later this year. A good argument can be made for waiting for those results before buying the stock, but of course that way you don't get any 50-baggers. <g>

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext